JNJ vs XRAY: Which Is the Better Dividend Stock?
As of Oct 19, 2026, JNJ (Johnson & Johnson) screens as the stronger dividend stock, winning 5 of 8 head-to-head metrics. JNJ offers the higher yield at 2.10%, XRAY has the higher dividend-safety score, and JNJ looks like the better value (its fair-value estimate is 22% below its share price).
Key facts: JNJ vs XRAY
Data as of · Source: SmarterDividends data
- As of Oct 19, 2026, Johnson & Johnson (JNJ) has the higher forward dividend yield at 2.10%, versus 1.87% for DENTSPLY SIRONA Inc. (XRAY).
- As of Oct 19, 2026, SmarterDividends grades JNJ's dividend safety A (94/100) and XRAY's A (95/100).
- By SmarterDividends' count as of Oct 19, 2026, JNJ has raised its dividend for 55 consecutive years and XRAY for 0.
- As of Oct 19, 2026, JNJ pays out 61% of its earnings as dividends and XRAY pays out 30%.
- As of Oct 19, 2026, JNJ's fair-value estimate is 22% below its share price and XRAY's fair-value estimate is 51% below its share price, so JNJ looks like the better value of the two on SmarterDividends' blended model.
Cite this page
SmarterDividends, "JNJ vs XRAY: Dividend Yield, Safety & Value Compared," updated Oct 19, 2026, https://smarterdividends.com/compare/jnj-vs-xray
| Metric | JNJ | XRAY |
|---|---|---|
| Forward yield | 2.10% | 1.87% |
| Annual dividend | $5.36 | $0.16 |
| Payout ratio | 61% | 30% |
| Years of growth | 55 yr | 0 yr |
| 5-yr dividend growth | 5.2% | 9.9% |
| 5-yr total return | 64% | -82% |
| Dividend safety score | 94 (A) | 95 (A) |
| Fair value estimate | $199.45 | $4.23 |
| Upside to fair value | -22% | -51% |
| Frequency | quarterly | quarterly |
| Market cap | $615.9B | $1.7B |
| P/E ratio | 38.8 | — |
Higher yield
JNJ
2.10%
Safer dividend
XRAY
Grade A
Faster growth
XRAY
9.9%
Better value
JNJ
-22% upside
JNJ vs XRAY — FAQ
Is JNJ or XRAY a better dividend stock?
On the data, JNJ wins more head-to-head categories (5 vs 3). JNJ offers the higher yield (2.10%), while XRAY has the stronger dividend-safety score. The right pick depends on whether you prioritise income, safety or value.
Which has a higher dividend yield, JNJ or XRAY?
JNJ has the higher forward dividend yield at 2.10%, versus 1.87% for XRAY.
Is JNJ or XRAY safer?
XRAY has the higher dividend-safety score (95/100 vs 94/100), reflecting stronger payout coverage and dividend-growth history.
Is JNJ or XRAY better value right now?
As of Oct 19, 2026, JNJ looks like the better value: its fair-value estimate is 22% below its share price (overvalued). For XRAY, its fair-value estimate is 51% below its share price.
Related comparisons
See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.